The effect of freezing and long-term storage on the stability of cardiac troponin T

American Journal of Clinical Pathology

Volumn 128, Issue 1, 2007, Pages 164-167

  Basit, Majid ^a   Bakshi, Nasir ^b   Hashem, Mustafa ^a   Allebban, Zuhair ^a   Lawson, Noel ^c   Rosman, Howard S ^a   Maciejko, James J ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; End stage renal disease; Hemodialysis; Sample stability; Sample storage; Troponin T

Indexed keywords

CREATININE; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FREEZING; HEART INFARCTION; HEMODIALYSIS; HUMAN; IMMUNOASSAY; KIDNEY FAILURE; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STORAGE; BLOOD; BLOOD STORAGE; MIDDLE AGED; TIME;

ADULT; AGED; BLOOD PRESERVATION; FEMALE; FREEZING; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TROPONIN T;

EID: 34547110373     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LR7FC0LUGLHT8X6J     Document Type: Article

References (14)

1. Mockel M, Schindler R, Knorr L, et al. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant. 1999;14:1489-1495.
2. Maynard SJ, Menown IB, Adgey AA. Troponin T or troponin I as cardiac markers in ischaemic heart disease. Heart. 2000;83:371-373.
3. Ohman EM, Armstrong PW, Christenson RH, et al, for the GUSTO-IIa Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1342.
4. Ooi DS, Zimmerman D, Graham J, et al. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem. 2001;47:412-417.
5. Baum H, Braun S, Gerhardt W, et al. Multicenter evaluation of a second-generation assay for cardiac troponin T. Clin Chem. 1997;43:1877-1884.
6. Woltersdorf WW, Bayly GR, Day AP. Practical implications of in vitro stability of cardiac markers. Ann Clin Biochem. 2001;38:61-63.
7. Kanwar M, Hashem M, Rosman H, et al. Usefulness of clinical evaluation, troponins and C-reactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol. 2006;98:1283-1287.
8. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med. 2003;115:178-184.
9. Ridker PM, Rifai N, Pfeffer MA, et al, for the Cholesterol and Recurrent Events (CARE) Investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100:230-235.
10. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest Suppl. 1999;230:128-131.
11. Lev EI, Osende JI, Zaman AG. Troponin T levels and abciximab therapy in unstable angina [letter]. N Engl J Med. 1999;341:1084-1085.
12. Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
13. White HD. Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction. Am Heart J. 1999;138(2 pt 2):S105-S114.
14. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-150.